EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Repurposed drug found to be effective against Zika virus

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked trans...
Continue Reading →
Europe

FDA approves new treatment for certain digestive tract cancers

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastroint...
Continue Reading →
Europe

Drug trial protocol redactions by industry sponsors exposed

New research published by the Journal of the Royal Society of Medicine exposes the extent of redactions in protocols for industry-sponsored randomised drug trials. Tr...
Continue Reading →
news

Meta-Analysis Shows One Kind of Brain Training Does Work

A systematic review and meta-analysis has just published in Neuroscience and Biobehavioral Reviews, and concludes that a specific type of computerized brain training ...
Continue Reading →
Europe

SafeHeal starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy

The study will evaluate safety and efficacy of the Colovac bypass device for ostomy-free anastomosis protection following colorectal surgery  SafeHeal, a leading inno...
Continue Reading →
Europe

SBRI Healthcare alumni company Owlstone Medical wins global IPF Catalyst Challenge

Share in $1,000,000 (£720,000 GBP) for real and innovative solutions to problems faced by Idiopathic Pulmonary Fibrosis sufferers One of only two UK finalists – ...
Continue Reading →
Europe

Metrion Biosciences acquires rights to small molecule potassium channel inhibitors from Japan Tobacco Inc.

Acquired intellectual property rights have potential application in a variety of clinical indications, including auto-immune disorders and neurodegenerative diseas...
Continue Reading →
news

ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC

ZZ Biotech today announced that preliminary results of RHAPSODY, the company’s Phase 2 clinical trial in acute ischemic stroke patients, were presented at the 2018 In...
Continue Reading →
news

Robocath sets up medical advisory board composed of international interventional cardiology key leaders

Robocath, a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases, announces today the creation of its medical adv...
Continue Reading →
Europe

Supplies of medicines could be disrupted when UK leaves EU says Brexit Health Alliance

Patients could find that supplies of their medicines will be disrupted when the UK leaves the EU,  according to the Brexit Health Alliance in a briefing paper publish...
Continue Reading →
Quotient